Next Article in Journal
Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
Next Article in Special Issue
Breast Reconstruction Use and Impact on Surgical and Oncologic Outcomes Amongst Inflammatory Breast Cancer Patients—A Systematic Review
Previous Article in Journal
Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada
Previous Article in Special Issue
Mesenchymal Tumors of the Breast: Fibroblastic/Myofibroblastic Lesions and Other Lesions
 
 
Review

Article Versions Notes

Curr. Oncol. 2023, 30(5), 4677-4687; https://doi.org/10.3390/curroncol30050353
Action Date Notes Link
article xml file uploaded 1 May 2023 08:25 CEST Original file -
article xml uploaded. 1 May 2023 08:25 CEST Update https://www.mdpi.com/1718-7729/30/5/353/xml
article pdf uploaded. 1 May 2023 08:25 CEST Version of Record https://www.mdpi.com/1718-7729/30/5/353/pdf
article html file updated 1 May 2023 08:26 CEST Original file https://www.mdpi.com/1718-7729/30/5/353/html
Back to TopTop